This is a pilot study. Volunteers will be given 1.8 mg (1.2 mg followed by 0.6 mg one hour later), 1.2 mg, or 0.6 mg of colchicine. Blood will be collected prior to drug administration, 2 hours after colchicine administration, and 24 hours after colchicine administration via the antecubital vein and evaluated for markers of platelet activity and inflammation.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Colchicine 1.2 mg followed by 0.6 mg one hour later
New York University School of Medicine
New York, New York, United States
Monocyte Platelet Aggregate: Baseline
Time frame: Baseline
Monocyte Platelet Aggregate: 2 Hours
Time frame: 2 Hours
Light Transmission Aggregometry: Baseline
In response to adenosine diphosphate
Time frame: Baseline
Light Transmission Aggregometry: 2 Hours
In response to adenosine diphosphate
Time frame: 2 hours
Light Transmission Aggregometry: Baseline
In response to adenosine epinephrine
Time frame: baseline
Light Transmission Aggregometry: 2 Hours
In response to adenosine epinephrine
Time frame: 2 hours
Platelet Adhesion: Baseline
Time frame: Baseline
Platelet Adhesion: 2 Hours
Time frame: 2 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.